Retatrutide vs. Semaglutide for Weight Loss—What’s the Difference?

Forbes·Jun 3

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Retatrutide, a weight-loss drug, has shown promising results in clinical trials, with some reports indicating it helped people lose a significant percentage of their body weight. The drug is being compared to other weight-loss treatments, including semaglutide and tirzepatide, with some outlets suggesting it may be as effective as weight-loss surgery. The exact differences and efficacy of retatrutide compared to other treatments are still being explored and reported on.

Full coverage

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

UCHealth·Jun 16

Retatrutide vs. Semaglutide for Weight Loss

Ro·May 14

Retatrutide vs. Tirzepatide: How Do They Compare?

GoodRx·Apr 20

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison | International Journal of Obesity

Nature·Feb 21

An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different.

Health: Trusted and Empathetic Health and Wellness Information·Jun 3

Retatrutide Helped Adults With Obesity Lose Up to 30 Percent of Their Body Weight in New Trial

Everyday Health·May 21

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Scientific American·Mar 19

Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial

CNBC·Dec 11

View original report at Forbes ↗

Fetching the latest headlines…